China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 23.3% in First Half of 2022

China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 767.7 million yuan in the first half of 2022, up 23.3% year-on-year.

Meanwhile, the company posted 4.9 billion yuan in revenue, up 6.1% year-on-year.

At the end of the reporting period, it had 13.9 billion yuan in total assets and 3.4 billion yuan in total liabilities, with a liability-to-asset ratio of 24.7%.